| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $76.5M | +14.4% |
| Cost of Revenue | $44.2M | +12.2% |
| Gross Profit | $32.3M | +17.5% |
| R&D Expense | $2.4M | -29.9% |
| SG&A Expense | $28.2M | +2.2% |
| Operating Income | $510K | +109.7% |
| Pre-tax Income | -$27.3M | -265.3% |
| Income Tax | $735K | +263.3% |
| Net Income | -$28.1M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | +27.6% |
| Accounts Receivable | $9.2M | — |
| Inventory | $6.6M | -5.8% |
| Current Assets | $29.0M | +8.7% |
| Total Assets | $47.8M | +8.3% |
| Current Liabilities | $23.8M | +28.1% |
| Long-term Debt | $13.5M | -24.9% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $159K | +104.0% |
| Capital Expenditures | $1.9M | +48.9% |
| Investing Cash Flow | -$3.0M | -135.5% |
| Financing Cash Flow | $4.1M | -7.4% |
| Free Cash Flow | -$1.8M | +66.2% |
| -288.9% |
| Total Liabilities |
| $39.1M |
| -0.2% |
| Stockholders' Equity | $8.7M | +85.1% |